Survival of infants diagnosed with encephalocele in Atlanta, 1979-98.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 12562471)

Published in Paediatr Perinat Epidemiol on January 01, 2003

Authors

Csaba Siffel1, Lee-Yang C Wong, Richard S Olney, Adolfo Correa

Author Affiliations

1: National Center on Birth Defects and Developmental Disabilities, CDC and Prevention, Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA. ACorrea@cdc.gov

Articles by these authors

Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00

Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 3.90

Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79

Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75

Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29

A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88

Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69

A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res (2004) 2.49

Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43

Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35

Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation (2010) 2.26

Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics (2003) 2.11

The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92

Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet (2004) 1.79

Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr (2008) 1.73

The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68

Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67

Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics (2009) 1.66

Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect (2004) 1.61

Ambient air pollution and preterm birth: a time-series analysis. Epidemiology (2009) 1.57

Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54

Quantifying geocode location error using GIS methods. Environ Health (2007) 1.48

Temporal trends in survival among infants with critical congenital heart defects. Pediatrics (2013) 1.45

Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43

Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care (2012) 1.43

Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38

FRIL: A tool for comparative record linkage. AMIA Annu Symp Proc (2008) 1.38

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35

Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34

Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32

Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.31

Seasonality of birth and implications for temporal studies of preterm birth. Epidemiology (2009) 1.28

Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics (2011) 1.28

Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Pediatrics (2013) 1.28

The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24

Residential mobility during pregnancy: patterns and correlates. Matern Child Health J (2009) 1.23

Lexicon, definitions, and conceptual framework for public health surveillance. MMWR Surveill Summ (2012) 1.20

Results from the New Jersey statewide critical congenital heart defects screening program. Pediatrics (2013) 1.20

Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med (2009) 1.18

Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: searching for population variations. Birth Defects Res A Clin Mol Teratol (2008) 1.18

Multistate study of the epidemiology of clubfoot. Birth Defects Res A Clin Mol Teratol (2009) 1.18

Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A (2011) 1.17

Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol (2004) 1.16

Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15

Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr (2006) 1.14

Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep (2011) 1.13

Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatr Perinat Epidemiol (2007) 1.13

Trisomies 13 and 18: population prevalences, characteristics, and prenatal diagnosis, metropolitan Atlanta, 1994-2003. Am J Med Genet A (2008) 1.13

Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13

Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol (2013) 1.13

Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol (2009) 1.12

Indoor charcoal smoke and acute respiratory infections in young children in the Dominican Republic. Am J Epidemiol (2009) 1.11

Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? J Reprod Med (2005) 1.11

Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol (2013) 1.10

Use of spline regression in an analysis of maternal prepregnancy body mass index and adverse birth outcomes: does it tell us more than we already know? Ann Epidemiol (2008) 1.08

Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol (2009) 1.07

Inter-rater reliability of assessed prenatal maternal occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup Environ Hyg (2011) 1.06

Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs. Birth Defects Res A Clin Mol Teratol (2012) 1.06

Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease. Circ Res (2017) 1.06

Association between congenital heart defects and small for gestational age. Pediatrics (2007) 1.04

Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med (2005) 1.04

Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol (2010) 1.02

Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol (2003) 1.02

Are encephaloceles neural tube defects? Pediatrics (2006) 1.01

The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Appl Health Econ Health Policy (2005) 1.01

Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01

Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study. Environ Health Perspect (2014) 1.00

Epidemiology of gastroschisis in metropolitan Atlanta, 1968 through 2000. Birth Defects Res A Clin Mol Teratol (2005) 1.00

The association between race/ethnicity and major birth defects in the United States, 1999-2007. Am J Public Health (2014) 0.98

Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol (2004) 0.98

Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics (2012) 0.98

Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005. Public Health Rep (2012) 0.97

An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol (2010) 0.97

Trihalomethane exposures from municipal water supplies and selected congenital malformations. Epidemiology (2003) 0.96

Sirenomelia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research, and literature review. Am J Med Genet C Semin Med Genet (2011) 0.96

Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med (2010) 0.96

Causes of death and case fatality rates among infants with down syndrome in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol (2007) 0.96

Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol (2010) 0.96

Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol (2004) 0.96

Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet (2003) 0.95

Observed prevalence of congenital heart defects from a surveillance study in China. J Ultrasound Med (2011) 0.95

Preferential associations between oral clefts and other major congenital anomalies. Cleft Palate Craniofac J (2008) 0.94

Challenges and priorities for surveillance of stillbirths: a report on two workshops. Public Health Rep (2009) 0.94

Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol (2008) 0.93

Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States. J Public Health Manag Pract (2016) 0.93

Evaluation of three retrospective exposure assessment methods. Ann Occup Hyg (2003) 0.92

Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology (2010) 0.92

Congenital heart defects and major structural noncardiac anomalies, Atlanta, Georgia, 1968 to 2005. J Pediatr (2011) 0.92

Long-term survival of infants with atrioventricular septal defects. J Pediatr (2010) 0.92

Hypospadias and intake of nutrients related to one-carbon metabolism. J Urol (2008) 0.91

Caffeine, selected metabolic gene variants, and risk for neural tube defects. Birth Defects Res A Clin Mol Teratol (2010) 0.91

Fine-grained record integration and linkage tool. Birth Defects Res A Clin Mol Teratol (2008) 0.91

Analysis of seasonal variation of birth defects in Atlanta. Birth Defects Res A Clin Mol Teratol (2005) 0.91

Maternal corticosteroid use and hypospadias. J Pediatr (2009) 0.91